Delivery Order SPE2DE21D0017-SPE2D626F35D3
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on December 3, 2025, for BinaxNOW COVID-19 antigen test cards. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by December 24, 2025, with performance taking place in Lake Mary, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for managing...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order for BinaxNOW COVID-19 antigen test cards valued at $3,015.15 under a fixed-price contract with economic price adjustment provisions. The award was issued on November 20, 2025, with an ultimate completion date of December 12, 2025, and will be performed in Lockhart, Florida. The contract carries no set-aside designation and was issued under a full and open competition basis by the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $4,020.20 for BinaxNOW COVID-19 antigen test cards. The contract was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, under a fixed-price arrangement with economic price adjustment provisions. The award was issued without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics Agency Medical Supply...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 15, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $2,412.12. This fixed-price contract with economic price adjustment was issued without a set-aside designation, indicating open competition. The award is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procurement of medical supplies to...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 23, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $21,106.05. This fixed-price contract with economic price adjustment was competitively awarded without set-aside designation and is funded by the Defense Logistics Agency (DLA) Medical Supply Chain. The ultimate completion date is May 14, 2025, and performance will take place in Lockhart, Florida. The...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,206.06 on August 22, 2025, for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment will be performed in Lockhart, Florida, with an ultimate completion date of September 15, 2025. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Defense Logistics Agency's Medical Supply...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F35D3Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award on December 17, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies for Department of Defense operations and supporting military healthcare readiness. The contract specifies performance at Lake Mary, Florida, and represents no set-aside designation, indicating full and open competition. Abbott Rapid DX North America LLC has established itself as a critical supplier of diagnostic testing solutions to federal healthcare agencies, with an extensive portfolio of prior awards for COVID-19 testing supplies and other point-of-care diagnostic products. This delivery order is structured under existing indefinite delivery vehicle contracts that Abbott maintains with the Defense Logistics Agency Medical Supply Chain, enabling efficient procurement of diagnostic testing products on an as-needed basis. Abbott's federal contracting portfolio demonstrates sustained performance across hundreds of delivery orders ranging from approximately $600 to $69,600, with primary funding originating from the Defense Logistics Agency and Veterans Integrated Service Networks. The BinaxNOW product line represents a core component of Abbott's federal diagnostic supply offerings, supporting government healthcare operations through rapid antigen testing capabilities. The ultimate completion date of January 9, 2026, reflects the near-term delivery requirements associated with this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/16/25 |